Загрузка...
Anticoagulation therapy using unfractionated heparin at a therapeutic dose for coronavirus disease 2019 patients with severe pneumonia: a retrospective historical control study
AIM: Patients with severe coronavirus disease 2019 (COVID‐19) pneumonia often have complications of coagulopathy and thrombotic phenomena, which lead to high mortality. Whether administering systematic anticoagulant therapy is beneficial remains unclear. We report our experience using systemic antic...
Сохранить в:
| Опубликовано в: : | Acute Med Surg |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8245744/ https://ncbi.nlm.nih.gov/pubmed/34221412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ams2.679 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|